In Memory of Sarah,
Help US Beat AML
For the first time, the necessary resources (researchers, the FDA, pharmaceutical and biotech companies) have come together to revolutionize how we study, test and treat AML (Acute Myeloid Leukemia). The Beat AML Master Clinical Trial’s precision medicine approach will match new drugs with patients based on their individual genetic markers. To learn more about the clinical trial, visit www.lls.org/beataml.
Because we lost our precious Sarah to AML, this battle is personal:
- AML is complex – having more than 10 different sub-types. Some, like Sarah’s, are resistant to standard treatment.
- AML is relentless – the standard treatment has not changed in over 40 years.
- AML is deadly – 3 in 4 patients do not survive five years beyond diagnosis. Some, like Sarah, lose their battle in a matter of weeks.
Because cancer touches all our lives in some way, this battle is personal for you:
- Half of men and one third of women will be diagnosed with cancer in their lifetime.
- The Beat AML Master Clinical Trial will not only find cures for AML, but will contribute to curing other cancers.
- Time is critical. Patients are waiting.
LLS has BIG plans - to raise $125 million by 2019 to invest in its Beat AML mission.
Tom and I plan to raise at least $5,000 by January, to secure Sarah’s legacy in the battle to defeat AML.
Will you please help?
Make a tax-deductible donation on this webpage TODAY!
Thank you for joining us in this battle and thank you for helping us to Make Someday TODAY!